FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Exosomes in Relapsing-Remitting MS Have Distinct RNA Profile



































Image Source: NEUROLOGYADVISOR

Circulating exosomes have a distinct RNA profile in relapsing-remitting multiple sclerosis (RRMS), according to a study published in the Annals of Neurology.

Igor Selmaj, MD, from the Medical University of Lodz in Poland, and colleagues used next generation sequencing to define the global RNA profile of serum exosomes in 19 RRMS patients and 10 healthy controls (HCs). Per sample, they analyzed 5,000,000 reads and over 50,000 transcripts, including a detailed analysis of microRNA (miRNA) differentially expressed in RRMS. The discovery data set was validated using data from an independent cohort of 63 RRMS patients (33 in relapse and 30 in remission) and 32 HCs.

The researchers found that in RRMS patients vs HCs, 15 different classes of transcripts detected 4 circulating exosomal sequences within the miRNA category that were differentially expressed: hsa-miR-122-5p, hsa-miR-196b-5p, hsa-miR-301a-3p, and hsa-miR-532-5p. During relapse there was a significant decrease of serum exosomal expression of these miRNA in RRMS. In patients with a gadolinium enhancement on brain magnetic resonance imaging, these miRNAs were also decreased. In RRMS, in vitro secretion of these miRNAs by peripheral blood mononuclear cells was significantly impaired.

"Since putative targets for these miRNA include the signal transducer and activator of transcription 3 and the cell cycle regulator aryl hydrocarbon receptor the data suggest a disturbed cell-to-cell communication in this disease," the authors write.

Story Source: The above story is based on materials provided by NEUROLOGYADVISOR
Note: Materials may be edited for content and length
Click here to read more

Labels:



Go to Newer News Go to Older News